We applaud Pennsylvania’s new law aligning coverage with the latest @AmericanCancer & @NCCN guidelines, expanding access to screening innovations like our Shield™ #BloodTest with no cost-sharing for approximately 2 million screening-eligible Pennsylvanians.
More:
Conquering Cancer With Data

